Haemonetics (STU:HAZ) Short Interest


STU:HAZ Haemonetics Corp STU:HAZ
25 GF Score
Price €65.50
GF Value €74.16
! 4 Warning Signs
View Full Analysis

What is Haemonetics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:HAZ vs ITGR, IRTC, ESTA: Short Interest Comparison

For the Medical Devices subindustry, Haemonetics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haemonetics Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Haemonetics's Short Interest distribution charts can be found below:

* The bar in red indicates where Haemonetics's Short Interest falls into.


STU:HAZ
25GF Score
Haemonetics Corp STU:HAZ
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Haemonetics (STU:HAZ) Overvalued in 2026?

Based on GuruFocus' analysis, Haemonetics stock appears to be undervalued. The current stock price of €65.50 is trading 11.7% below its estimated GF Value™ of €74.16.

Key valuation signals for STU:HAZ:

  • Short Interest:
  • GF Value™: €74.16 vs. price of €65.50 (11.7% below fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the STU:HAZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haemonetics Business Description

Other Exchanges HAE:USA
Address 125 Summer Street, Boston, MA, USA, 02110
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
25GF Score

Get the complete analysis for STU:HAZ

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.50
Price
€74.16
GF Value